Allara Health, a NYC-based virtual care platform bridging the care divide for women battling chronic hormonal conditions, raised $26m in Series B funding.
The round, which brought total funding to $38.5m, was led by Index Ventures (with partner Martin Mignot joining Allara’s board), with participation from existing investor GV (Google Ventures).
The company intends to use the funds to bring specialised care to women nationwide struggling with hormonal conditions.
Related: PhotoniCare collects $4.6m in Series B funding
Today, 1 in 3 women will battle a chronic hormonal condition in their lifetimes, including polycystic ovarian syndrome (PCOS), endometriosis, and hypothyroidism – all of which can cause health challenges like infertility, high-risk pregnancies, obesity, and diabetes. For those struggling, receiving a diagnosis and finding high-quality, supportive care can be difficult: close to 70 percent of PCOS cases are undiagnosed, and it can take an average of ten years to receive an endometriosis diagnosis. Moreover, a study from KFF of women ages 18-64 found that close to 30 percent felt that their doctor had dismissed their concerns, leaving women to manage symptoms and long-term side effects on their own.
Led by founder and CEO Rachel Blank, Allara is a specialty care platform built for women living with complex hormonal and gynecologic conditions, such as polycystic ovary syndrome (PCOS) and endometriosis. The solution makes expert healthcare accessible online by connecting patients with expert medical practitioners and Registered Dietitians who have a deep understanding of hormonal and metabolic care. Allara provides ongoing medical, lifestyle, and emotional support for chronic conditions, helping patients see improved health outcomes and achieve their individualised goals.
